Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-04-05
2011-04-05
Huynh, Phuong (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007210, C435S007900, C435S007950, C435S008000, C536S023400, C536S023500
Reexamination Certificate
active
07919248
ABSTRACT:
The present invention is drawn to methods for modulating IL-13 expression and/or activity in a mammal comprising administering an effective amount of an agent which modulates the expression and/or activity of IL-9.
REFERENCES:
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 4703004 (1987-10-01), Hopp et al.
patent: 4761375 (1988-08-01), Clark
patent: 5116951 (1992-05-01), Druez et al.
patent: 5132109 (1992-07-01), Dugas et al.
patent: 5157112 (1992-10-01), Van Snick et al.
patent: 5164317 (1992-11-01), Hultner et al.
patent: 5180678 (1993-01-01), Druez et al.
patent: 5208218 (1993-05-01), Van Snick et al.
patent: 5246701 (1993-09-01), Dugas et al.
patent: 5414071 (1995-05-01), Yang et al.
patent: 5531219 (1996-07-01), Rosenberg
patent: 5693762 (1997-12-01), Queen et al.
patent: 5908839 (1999-06-01), Levitt et al.
patent: 6037149 (2000-03-01), Levitt et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6261559 (2001-07-01), Levitt et al.
patent: 6645492 (2003-11-01), Levitt et al.
patent: 0361284 (1990-04-01), None
patent: 903150 (1999-03-01), None
patent: WO 90/14432 (1990-11-01), None
patent: WO 91/10738 (1991-07-01), None
patent: WO 91/14767 (1991-10-01), None
patent: WO 92/05698 (1992-04-01), None
patent: WO 97/08321 (1997-03-01), None
Renauld et al, J Clin Pathol 54: 577-589, 2001.
Cheng et al. (2002) Antil-Interleukin-9 Antibody Treatment Inhibits Airway Inflammation and Hyperreactivity in Mouse Asthma Model, Am. J. Respir. Crit. Med. 166:409-416.
Doull et al. (1996) Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness, Am. J. Respir. Crit. Care Med. 153:1280-1284.
Grunig et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma, Science 282:2261-2263.
Huang et al. (1995) IL-13 expression at the sites of allergen challenge in patients with asthma, J. Immunol. 155:2688-2694.
Humbert et al. (1997) Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma, J. Allergy Clin. Immunol. 99:657-665.
Kang et al. (1995) Activation of junB and c-myc primary response genes by interleukin 9 in a human factor-dependent cell line, J Cell Physiol. 163:623-30.
Kermouni et al. ()995) The IL-9 receptor gene (IL9R): genomic structure, chromosomal localization in the pseudoautosomal region of the long arm of the sex chromosomes, and identification of IL9R pseudogenes at 9qter, 10pter, 16pter, and 18pter, Genomics. 29:371-82.
Klimka et al. (1996) A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines, Cytokines Mol Ther. 2:139-46.
Kung et al. (2001) Effect of Anti-mIL-9 Antibody on the Development of Pulmonary Inflammation and Airway Hyperresponsiveness in Allergic Mice, Am. J. Respir. Cell Mol. 25:600-625.
Leigh et al. (2004) Is Interleukin-13 Critical in Maintaining Airway Hyperresponsiveness in Allergen-challenged Mice, Am. J. Respir. Crit. Care Med. 851-856.
Lemoli et al. (1995) Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells, Haematologica 80:5-12.
Levitt et al. (1988) Expression of airway hyperreactivity to acetylcholine as a simple autosomal recessive trait in mice, FASEB J. 2:2605-2608.
Levitt et al. (1994) A locus regulating bronchial hyperresponsiveness maps to chromosome 5q, Amer. J. Human Genetics 55:1120.
Lopez-Valpuesta et al. (1995) Cytokines and thermoregulation: interleukin-9 injected in preoptic area fails to evoke fever in rats, Brain Res Bull. 36:181-4.
Marsh et al. (1994) Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations, Science 264:1152-1156.
McKenzie et al. (1993) Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function, Proc. Natl. Acad. Sci. U.S.A. 90:3735-3739.
Meyers et al. (1994) Evidence for a locus regulating total serum IgE levels mapping to chromosome 5, Genomics 23:464-470.
Minty et al. (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses, Nature 362:248-250.
Mustafa et al. (2001) Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever, FEMS Immunol. Med. Microbiol. 30:229-233.
Nassar et al. (1994) Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes, J. Biol. Chem. 269:27631-27634.
Oshima et al. (2001) Interleukin-13 and interleukin-13 receptor in Hodgkin's disease possible autocrine mechanism and involvement in fibrosis, Histopathology 38:368-375.
Oriente et al. (2000) Interleukin-13 modulates collagen homeostatis in human skin and keloid fibrolasts, J. Pharmacol. Exp. Ther. 292:988-994.
Renauld et al. (1990) Expression in activated CD4+ T cells, genomic organization, and comparison with the mouse gene, J Immunol. 144:4235-4241.
Renauld et al. (1992) Expression cloning of the murine and human interleukin 9 receptor cDNAs, Proc Natl Acad Sci USA 89:5690-5694.
Renauld et al. (1995) Interleukin-9: structural characteristics and biologic properties, Cancer Treat Res. 80:287-303.
Renauld et al. (1995) Interleukin-9 and its receptor: involvement in mast cell differentiation and T cell oncogenesis, J Leukoc Biol. 57:353-60.
Renauld et al. (1996) Interleukin-9, Human Cytokines: Handbook for Basic and Clinical Research 549-559.
Rook et al. (2001) Advances in the immunopathogenesis of pulmonary tuberculosis, Curr. Opin. Pulm. Med. 7:116-123.
Rosenwasser et al. (1996) Transcriptional regulation of the human IL-9 gene in asthma and atopy, J. Investigative Medicine 44:205.
Spanbroek et al. (2001) IL-4 determines eicosanoid formation in dendritic cells by down regulation of 5-lipoxygenase and up-regulation of 15-lipoxygena 1 expression, Proc Natl Acad Sci USA 98:5152-5157.
Tenmann et al. (1998) Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness, J. Exp. Med. 188:1307-1320.
Townsend et al. (2000) IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development, Immunity 13:573-583.
Vermeesch et al. (1995) The IL-9 receptor gene is located in the pseudoautosomal region of the long arm of the sex chromosomes, is expressed from the X and Y chromosome and its murine homologue is located on an autosome, Chromosome Research 3:105.
Walker et al. (1992) Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage, Am. Rev. Respir. Dis. 146:109-115.
Wills-Karp et al. (1998) Interleukin-l3: central mediator of allergic asthma, Science, 282:2258-2261.
Yin et al. (1994) JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes, J Biol Chem. 269:26614-26617.
Yin et al. (1995) Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases, J Biol Chem. 270:20497-502.
Yin et al. (1995) Tyrosine phosphorylation and activation of JAK family tyrosine kinases by interleukin-9 in MO7E cells, Blood 85:3101-3106.
Zhu et al. (1996) Multiple transcription factors are required for activation of human interleukin 9 gene in T cells, J Biol Chem. 271:15815-15822.
Zhu et al. Identification of critical regulatory regions in human interleukin 9 gene promoter, BLOOD, J. Amer. Soc. Hematology 86:2150 (1995).
Zhu et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production, J. Clin. Invest. 103:779-788.
Levitt Roy C.
Louahed Jamila
McLane Michael
Nicolaides Nicholas C.
Zhou Yuhong
Huynh Phuong
Ligand Pharmaceuticals Incorporated
Morgan & Lewis & Bockius, LLP
LandOfFree
Methods for the modulation of IL-13 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the modulation of IL-13, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the modulation of IL-13 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2731985